- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
- The Price Conversion is only for the Indicative purpose.
- USD — US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
-
Sector Analysis
Sector Analysis Age-Related Macular Degeneration in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2031 Age-Related Macular Degeneration in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2031
$10,995 | December 2023 Age-Related Macular Degeneration Market Report Overview The Age-Related Macular Degeneration (AMD) market sales across the 7MM was $7.36 billion in 2021. Drug sales in the AMD pharmacotherapy market are expected to grow at a compound annual growth rate (CAGR) of more than 14% between 2021 and 2031. An increase in the number of people with AMD, in line with the growth of the global aging population will drive the market growth during the forecast period. AMD is a progressive eye...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.